Analgesics in Taiwan, China

November 2026

Analgesics in Taiwan, China delivers steady growth in 2026 despite headwinds from import inflation, supply chain disruption, and a modest population decline. This performance, underpinned by robust economic expansion and resilient consumer spending, highlights the continued attractiveness of analgesics, particularly as demand is reinforced by an ageing population and the popularity of self-medication for pain management. Brands able to secure strong pharmacist endorsement, invest in visible in-store presence, and maintain trust through ingredient transparency and targeted communication are best placed to capture recurring demand, especially as regulatory tightening and the removal of national health insurance coverage for many pain-relief medicines reinforce reliance on approved, over-the-counter solutions. The shift towards pharmacy-driven purchasing and a focus on both topical and systemic remedies present opportunities for agile companies to innovate in delivery formats and adapt commercial strategies in response to margin pressures and evolving shopper behaviour.

USD 1,195
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Analgesics industry in Taiwan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Analgesics industry in Taiwan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Analgesics in Taiwan report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Analgesics in Taiwan?
  • Which are the leading brands in Analgesics in Taiwan?
  • How are products distributed in Analgesics in Taiwan?
  • How has the regulatory and operating environment for Analgesics changed in Taiwan?
  • How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
  • How significant are wider health concerns and consumer awareness in determining sales?
  • Where is future growth expected to be most dynamic?

Key Data Insights

Key Industry Trends

Cost pressures and demographic shifts sustain demand for trusted brands
Topical analgesics leads as the ageing population drives recurring-use demand
Regulatory tightening channels demand back to licensed, trusted products
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Pharmacists to shape purchase decisions as channel influence rises
Topical pain relief formats will expand as new preferences emerge
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Panadol sustains its leadership as regulatory changes drive OTC demand
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies retain shopper trust as regulations restrict online sales
Microneedle patch innovation targets pain relief for seniors
Chart 1 Retail Channels 2021-2026
Panadol uses price increases and airport campaigns to defend brand power and shelf presence
Eve restrictions and Taiwan FDA enforcement shift demand to licensed, pharmacist-recommended brands
Chain pharmacies use commercial margins and microneedle patch innovation to protect profitability
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031

Country Reports Disclaimer

The following categories and subcategories are included:

Analgesics

      • Adult Acetaminophen
      • Adult Aspirin
      • Adult Combination Products - Analgesics
      • Adult Diclofenac
      • Adult Dipyrone
      • Adult Ibuprofen
      • Adult Ketoprofen
      • Adult Naproxen
      • Adult OTC Triptans
      • Paediatric Acetaminophen
      • Paediatric Aspirin
      • Paediatric Combination Products - Analgesics
      • Paediatric Dipyrone
      • Paediatric Ibuprofen
      • Paediatric Naproxen
      • Acetaminophen
      • Aspirin
      • Combination Products - Analgesics
      • Diclofenac
      • Dipyrone
      • Ibuprofen
      • Ketoprofen
      • Naproxen
      • OTC Triptans
  • Topical Analgesics/Anaesthetic

Analgesics

Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).

See all of our definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Analgesics research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!